HYQure Biotech relies on international compliance standards, leverages excellent quality and technical strength, and has built a one-stop Biosafety service platform focusing on large molecule drugs and CGT drugs. It has passed the EU QP, CNAS, and ISO9001 audit certifications, meeting the strict requirements of global regulatory agencies such as NMPA, FDA, and EMA, providing reliable assurance for innovative pharmaceutical companies.
HYQure Biotech has served 300+ biopharmaceutical companies, with rich experience in project and application, and has provided key support for more than 80 clinical and marketing applications of biopharmaceuticals, including more than 40 Sino-US dual-reporting projects, offering services such as virus clearance validation, cell bank identification, commercial batch release, replication-competent virus (RCL, rcAAV, RCR, etc.) testing, and services such as HCD and HCP kit and testing.
Company Details
- Employees
- 5
- Founded
- 2020
- Address
- Room K16
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.hengyudetc.com/cn
Hyqure Biotech Questions
Hyqure Biotech's website is https://www.hengyudetc.com/cn
Hyqure Biotech's LinkedIn profile is https://www.linkedin.com/company/hyqure
Hyqure Biotech has
5 employees.
View email and phone details for 5
employees at Hyqure Biotech.
Hyqure Biotech's industry is
Biotechnology Research
Hyqure Biotech's top competitors are
Medigene Ag,
Bora Pharmaceuticals,
Andera Partners,
Chime Biologics,
Duoning,
T&l Biotechnology,
Vms Group,
Topgene Biotechnology,
Zheng Yang Biomedical Technology,
Alioth Biotech.
Hyqure Biotech's categories are Biotechnology Research
Hyqure Biotech's founding year is 2020
